Document:

Blocker Letter Agreement

	
	
	EXHIBIT 10.01

TO:        Dewey Blocker
CC:        Payroll, HR and Personnel File
FROM:    Brian O’Callaghan
DATE:        March 24, 2015
RE:        Vice President of Finance Promotion
                                                        

Congratulations on your promotion to Vice President of Finance.  We are excited that you have accepted this promotion and look forward to your continued success with the Company.  The terms of this new role are as follows:

		
	•
	The promotion will be effective as of March 24, 2015.

		
	•
	The title is Vice President of Finance.  You will work with HR and me to have a job description in place no later than July 31, 2015.

		
	•
	Until a CFO is hired, you will oversee all Finance operations.

		
	•
	Your executive status will be as Named Executive Officer (“NEO”).  As such, your new role will be detailed in the annual Proxy Statement and 10-K, and any compensation approved will be disclosed to the SEC and/or the TSE as applicable.

Base Salary:  $270,300
Promotion Equity Grant of:  40,000 options and 20,000 RSUs
Annual Bonus Target:  35% of Base Salary (subject to achievement of individual and Company performance objectives).
Annual Base Salary Review:  As Vice President and NEO, your Base Salary will go through the Compensation Committee review for all individuals at this level, and final approval will be made by the Board of Directors.

As Vice President of Finance, you will perform such duties and responsibilities as may from time to time be assigned to you by the Company, commensurate with your title and position.  You agree that to the best of your ability and experience you shall at all times conscientiously perform all of the duties and obligations assigned to you and that are customary and standard for a vice president position.  Your primary work location will continue to be the Seattle office; provided that your duties will include reasonable travel, including but not limited to travel to offices of vendors and customers as is reasonably necessary and appropriate to the performance of your duties.  You will continue to comply with and be bound by the Company's operating policies, procedures, and practices from time to time in effect during your employment.  Additionally, you will ensure that operations, activities, and responsibilities are carried out efficiently, effectively and in compliance with contractual obligations with partners, and local, state, and federal laws, and applicable industry regulations.  This promotion does not alter the at-will nature of your employment relationship with Acucela.  The at-will provision and all other provisions of your October 10, 2008 offer letter with the Company, except as modified by this memorandum, shall continue to apply to your employment.

Acucela, Inc.
By: /s/ Brian O'Callaghan                 
Brian O’Callaghan, Chief Executive Officer

READ, UNDERSTOOD AND AGREED:

/s/Dewey H. Blocker, Jr.                Date:      March 24, 2015             
Dewey Blocker

1301 Second Avenue, Suite 4200   Seattle, WA  98101-3805   (P) 206.805.8300EX-10.35

 Exhibit 10.35 

AMENDMENT 

TO 
 MEDBOX,
INC. DIRECTOR RETENTION AGREEMENT 
 This Amendment (this “Amendment”) to the Medbox, Inc. Director
Retention Agreement (as defined below) is made and entered into as of December    , 2014 by Medbox, Inc., a Nevada corporation (the “Company”), and Ned L. Siegel (the “Director”). Capitalized
terms used but not defined herein shall have the respective meanings assigned to them in the Director Retention Agreement.  

WHEREAS, the Director is a member of the Board of Directors of the Company (the “Board”), and the Company and the
Director entered into that certain Medbox, Inc. Director Retention Agreement, dated as of April 1, 2014 (the “Director Retention Agreement”), pursuant to which the Director serves as a member of the Board and is compensated for
such service; 
 WHEREAS, the Board has determined that the Company make certain amendments to the Director’s compensation under
the Director Retention Agreement as further described herein; and 
 WHEREAS, the Company and the Director desire to enter into this
Amendment to effectuate such amendments to the Director Retention Agreement; 
 NOW, THEREFORE, in consideration of the foregoing, the
mutual promises of the parties hereto and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the parties hereto hereby agree to amend the Director Retention Agreement as follows: 

1. Amendment to Section 7 of the Director Retention Agreement. Section 7 of the Director Retention Agreement is
hereby amended by adding the following subsection (e) at the end thereof: 
  

	 	(e)	In the event that the Director is removed from the Board for any reason on or prior to March 31, 2016, (i) all of the Director’s unvested shares of RS and unvested RSUs granted under the Notice of Grant
and Restricted Stock Award Agreement and the Restricted Stock Unit Award Agreement, in each case, to be entered into between the Director and the Company shall immediately vest on the date of such removal, and all of the Director’s vested RSUs
shall be paid out on the date of such removal, except for the Director’s vested RSUs granted pursuant to the First Year Inducement Grant under Section 5.3(a)(ii), which shall be paid out in accordance with the original schedule set forth
in Section 5.3(a)(ii), and (ii) the aggregate amount of all Director Fees the Director would have earned for the remainder of the term of this Agreement and the additional term of this Agreement beginning April 1, 2016 and ending
March 31, 2017 if the Director had not been removed from the Board shall become immediately due and payable to the Director in one lump-sum payment on the date of such removal. 

 2. Miscellaneous. 

2.1 All other provisions of the Director Retention Agreement not specifically referenced herein shall remain in full and force and effect.

 2.2 In the event of a conflict between this Amendment and the Director Retention Agreement, this Amendment shall govern. 

2.3 The Director Retention Agreement may only be amended further by a written agreement executed by the parties hereto. 

2.4 This Amendment may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts shall
each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. 
 [Signature page
follows.] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the date
first above written. 
  

			
	MEDBOX, INC.
		
	By:		  

			Name:
			Title:
	
	  

	Ned L. SiegelEX-10.37

 Exhibit 10.37 

AMENDMENT 

TO 
 EMPLOYMENT
AGREEMENT 
 This Amendment (this “Amendment”) to the Employment Agreement (as defined below) is made and
entered into as of December    , 2014 by Medbox, Inc., a Nevada corporation (the “Company”), and Guy Marsala (the “Executive”). Capitalized terms used but not defined herein shall have the
respective meanings assigned to them in the Employment Agreement.  
 WHEREAS, the Company and the Executive entered into that
certain Employment Agreement, dated as of July 23, 2014 (the “Employment Agreement”), pursuant to which the Executive is engaged to serve as the President and Chief Executive Officer of the Company; 

WHEREAS, the Board of Directors has determined that the Company make certain amendments to the Employment Agreement as further described
herein; and 
 WHEREAS, the Company and the Executive desire to enter into this Amendment to effectuate such amendments to the Employment
Agreement; 
 NOW, THEREFORE, in consideration of the foregoing, the mutual promises of the parties hereto and other good and valuable
consideration, the receipt and sufficiency of which hereby are acknowledged, the parties hereto hereby agree to amend the Employment Agreement as follows: 

1. Amendment to Section 7(b) of the Employment Agreement. Section 7(b) of the Employment Agreement shall be
amended by adding the following at the end thereof: 
 In the event of termination of the Executive by the Company pursuant to
Section 6(b) or by the Executive pursuant to Section 6(c), in addition to the Accrued Compensation and the Termination Benefits to which the Executive is entitled under this Section 7(b) and subject to the Executive’s execution
and delivery (and non-revocation) of the Release Agreement within the Release Period, the Company shall provide to the Executive, within ten (10) days following the end of the Release Period, (i) an award of shares of the Company’s
common stock equal to the same number of shares of the Company’s common stock subject to RSUs that the Executive received as the Stock Award pursuant to Section 4(e) on the anniversary date of this Agreement occurring immediately prior to
the date of such termination; and (ii) an award of shares of the Company’s common stock equal to a number of shares that is two (2) times the full amount of the award of the Company’s common stock comprising the Annual Bonus
under Section 4(b) that has been determined by the Board of Directors for the twelve (12) month period following the anniversary date of this Agreement within which such termination occurs (the “Termination Year”) or for
the twelve (12) month period immediately preceding the commencement of the Termination Year if the Board of Directors has not made such determination by the date of such termination, as the case may be, but which shall be reduced by all amounts
of the award of the 

 
Company’s common stock comprising the Annual Bonus in respect of the Termination Year received by the Executive prior to the date of such termination (such awards referred to the foregoing
clauses (i) and (ii), collectively, the “Termination Awards”). All stock underlying each Termination Award shall be fully vested upon issuance. 

2. Miscellaneous. 

2.1 All other provisions of the Employment Agreement not specifically referenced herein shall remain in full and force and effect. 

2.2 In the event of a conflict between this Amendment and the Employment Agreement, this Amendment shall govern. 

2.3 The Employment Agreement may only be amended further by a written agreement executed by the parties hereto. 

2.4 This Amendment may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts shall
each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. 
 [Signature page
follows.] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the date
first above written. 
  

			
	 MEDBOX, INC.

		
	By:		  

			 Name:

			 Title:

	
	  

	Guy Marsala

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}]]